EUCTR2012-000413-36-GB进行中（未招募）1 期
ACE-EPIC: ACE inhibitors to enhance the effects of pulmonary rehabilitation in COPD - ACE-EPIC: Enhancing the effects of pulmonary rehabilitation in COPD
Imperial College0 个研究点目标入组 80 人开始时间: 2012年3月28日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •GOLD stage II-IV COPD
- •Clinical indication for PR (MRC score of >3 or functionally limited)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 40
排除标准
- •Clinically unstable patients (within one month of exacerbation), those with a permanent pacemaker (which is a contraindication to magnetic stimulation), or significant co-morbidity, patients with an accepted indication for ACE inhibition (left ventricular dysfunction, diabetes) or a contraindication such as renovascular disease; creatinine clearance (estimated) <50); hypotension; use of anticoagulants (contra-indication to biopsy) or ACE-I or ATII receptor antagonists.
- •Allergy to ACE-inhibitors.
研究者
相似试验
尚未招募
不适用
The effectiveness of ACE-Inhibitor for preventing pneumonia; Systematic review and meta-analysisPneumoniaJPRN-UMIN000039424Shiga University of Medical Science Hospital, Department of family medicine
已完成
不适用
ACE inhibitors to augment the effects of pulmonary rehabilitation in COPDISRCTN79038750Imperial College London (UK)80
已完成
不适用
Angiotensin Converting Enzyme (ACE) inhibition for the preservation of renal function and patient survival in kidney transplantatioChronic kidney disease in renal transplant patientsUrological and Genital DiseasesChronic kidney diseaseISRCTN78129473Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute528
进行中（未招募）
不适用
Study within children with Duchenne Muscular DystrophyEUCTR2009-009871-36-DEFriedrich- Alexander- Universität Erlangen Nürnberg
已完成
2 期
Effect and Safety of preventive Treatment with ACE-Inhibitor and Beta-Blocker on the onset of Left Ventricular Dysfunction in Duchenne Muscular DystrophyI50Heart failureDRKS00000115Friedrich- Alexander- Universität Erlangen Nürnberg,Universitätsklinikum , Dekan42